HARVARD BIOSCIENCE INC - Common Stock (HBIO)

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock
Shares outstanding
44,666,667
Total 13F shares
17,166
Share change
0
Total reported value
$91,838
Price per share
$5.35
Number of holders
1

Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2023

As of 31 Dec 2023, HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 17,166 shares. The largest 10 holders included B. Riley Asset Management, LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., BlackRock Inc., Harvey Partners, LLC, AMH Equity Ltd, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Granahan Investment Management, LLC, ROYCE & ASSOCIATES LP, and BOOTHBAY FUND MANAGEMENT, LLC. This page lists 91 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.